# OnCo record adriatic (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/adriatic/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "adriatic", "NCT03703297" ;
  schema:name "ADRIATIC"@en ;
  schema:description "ADRIATIC brought the first improvement in curative-intent small-cell lung cancer treatment in 30 years: a year or two of immunotherapy after chemoradiation lengthens life."@en ;
  schema:url <https://onco.cc/trials/adriatic/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03703297>, <https://www.onclive.com/view/fda-approves-durvalumab-for-limited-stage-small-cell-lung-cancer> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2018-09-27" ;
  onco:cancers <https://onco.cc/cancers/sclc/>, <https://onco.cc/cancers/limited-stage-sclc/> ;
  onco:technologies <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/prophylactic-cranial-irradiation/> ;
  onco:drugs <https://onco.cc/drugs/durvalumab/> ;
  onco:companies <https://onco.cc/companies/astrazeneca/> ;
  onco:terms <https://onco.cc/terms/limited-extensive-stage/>, <https://onco.cc/terms/pci-term/> ;
  onco:people <https://onco.cc/people/corinne-faivre-finn/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-adriatic-nejm-2024/> .